Edition:
United Kingdom

Oasmia Pharmaceutical AB (OASM.OQ)

OASM.OQ on NASDAQ Stock Exchange Capital Market

3.05USD
18 Sep 2018
Change (% chg)

-- (--)
Prev Close
$3.05
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
5,636
52-wk High
$3.16
52-wk Low
$0.80

Latest Key Developments (Source: Significant Developments)

Oasmia Pharma Q1 operating loss narrows slightly yr/yr
Friday, 31 Aug 2018 

Aug 31 (Reuters) - Oasmia Pharmaceutical AB ::Q1 CONSOLIDATED NET SALES AMOUNTED TO TSEK 128 COMPARED TO TSEK 20 IN Q1 PREVIOUS YEAR.SAYS OPERATING LOSS WAS TSEK 26,572 COMPARED TO TSEK 28,421 IN Q1 PREVIOUS YEAR.  Full Article

Oasmia Pharmaceutical Says May Offer, Issue, Sell Up to US$25 Mln Shares
Monday, 30 Apr 2018 

April 30 (Reuters) - Oasmia Pharmaceutical AB ::OASMIA PHARMACEUTICAL AB -MAY OFFER, ISSUE, SELL UP TO US$25 MILLION OF SHARES/ADSS, NUMBER OF WARRANTS TO PURCHASE ORDINARY SHARES, COMBINATION OF SECURITIES.  Full Article

Oasmia Pharmaceutical Q2 operating loss shrinks
Friday, 1 Dec 2017 

Dec 1 (Reuters) - Oasmia Pharmaceutical Ab ::OASMIA PHARMACEUTICAL AB Q2 ‍CONSOLIDATED NET SALES AMOUNTED TO TSEK 1,651 COMPARED TO TSEK 56 IN THE SECOND QUARTER THE PREVIOUS YEAR ​.OASMIA PHARMACEUTICAL AB Q2 ‍OPERATING LOSS WAS TSEK 22,129 COMPARED TO TSEK 35,867 IN THE SECOND QUARTER THE PREVIOUS YEAR ​.  Full Article

Oasmia Q4 operating loss widens
Thursday, 8 Jun 2017 

June 8 (Reuters) - Oasmia Pharmaceutical Ab ::Q4 consolidated net sales amounted to 44,000 SEK compared to 59,000 in q4 previous year.Q4 operating loss was 37 mln SEK compared to a loss of 31 mln SEK in q4 previous year.Says the board does not intend to propose any dividends for the financial year May 1, 2016 – April 30, 2017..  Full Article

BRIEF-Oasmia Pharmaceutical Says May Offer, Issue, Sell Up to US$25 Mln Shares

* OASMIA PHARMACEUTICAL AB -MAY OFFER, ISSUE, SELL UP TO US$25 MILLION OF SHARES/ADSS, NUMBER OF WARRANTS TO PURCHASE ORDINARY SHARES, COMBINATION OF SECURITIES Source text (https://bit.ly/2vZYiIp) Further company coverage: